CEO Julian Rees named 2023 Activate Fellow

HOPO Therapeutics CEO Dr. Julian Rees has been named a 2023 Activate Fellow. This prestigious 2-year fellowship for scientist-entrepreneurs is designed to support and accelerate the development of technologies with the potential to change the world, and will enable HOPO’s advancement of multiple programs in the defense, medicine, and global health spheres. As part of the fellowship, HOPO Therapeutics will join Berkeley Lab’s Cyclotron Road program.

Founded in 2015, Activate empowers scientists to reinvent the world by launching startups to address climate change and other global challenges. Working between government, philanthropy, universities, and the private sector, Activate transforms scientists into high-impact entrepreneurs through the Activate Fellowship, a two-year immersive experience that provides funding and fosters the resources, knowledge, networks, investors, and partnerships that fellows need to succeed. Activate is a 501(c)3 nonprofit and does not charge any fee or equity for fellows to participate. Activate’s entrepreneurial fellowship model originated from the Cyclotron Road program at Lawrence Berkeley National Laboratory, a founding Activate partner. Activate supports fellows in communities across the U.S.: Activate Berkeley, Activate Boston, Activate New York, and Activate Anywhere, and will be launching Activate Houston in 2024. Learn more at Activate.org.